-+ 0.00%
-+ 0.00%
-+ 0.00%

ZEVRA THERAPEUTICS: EXPECTS TO CONTINUE ENGAGEMENT WITH THE U.S. FDA IN THE H2 2026 TO EXPLORE PATHWAYS TO ACCELERATE CLINICAL DEVELOPMENT

路透·08/05/2026 20:05:08

登錄查看新聞詳情